| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |